Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 09-06-2020 | Practice Area: | Equity Capital Markets |
| Deal Title: | Kezar Life Sciences Underwritten Common Stock Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Kezar Life Sciences, Inc., a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmune disease and cancer, announced the pricing of an underwritten public offering of 7,590,909 shares of its common stock, and to certain investors in lieu thereof, pre-funded warrants to purchase 909,091 shares of its common stock at an exercise price of USD0.001 per share. The public offering price of each share of common stock was USD5.50 and the public offering price of each pre-funded warrant was USD5.499 per underlying share.
Latham and Watkins LLP represents the underwriters in the offering.
|
||
| Financial Center: | Silicon Valley | Value: | 0.00-100.00 |
| Advised Party: | Underwriter | Law Firm | Latham & Watkins |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NYSE: |
Lawyer | Brian Cuneo |
